Dulaglutida (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dulaglutida" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

2^nd place

68^th place

91^st place

low place

9,811^th place

diabetesjournals.org

Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z (agosto de 2014). «Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)». Diabetes Care 37 (8): 2149-58. PMID 24742660. doi:10.2337/dc13-2761. Consultado el 1 de marzo de 2015.
Amblee A (abril de 2014). «Dulaglutide for the treatment of type 2 diabetes». Drugs Today 50 (4): 277-89. PMID 24918645. doi:10.1358/dot.2014.50.4.2132740.
Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E (febrero de 2014). «Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials». Diabetes Res. Clin. Pract. 103 (2): 269-75. PMID 24485345. doi:10.1016/j.diabres.2014.01.010.

Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z (agosto de 2014). «Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)». Diabetes Care 37 (8): 2149-58. PMID 24742660. doi:10.2337/dc13-2761. Consultado el 1 de marzo de 2015.
Amblee A (abril de 2014). «Dulaglutide for the treatment of type 2 diabetes». Drugs Today 50 (4): 277-89. PMID 24918645. doi:10.1358/dot.2014.50.4.2132740.
Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E (febrero de 2014). «Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials». Diabetes Res. Clin. Pract. 103 (2): 269-75. PMID 24485345. doi:10.1016/j.diabres.2014.01.010.